Cargando…

Improved Prognostic Prediction in Never-Smoker Lung Cancer Patients by Integration of a Systemic Inflammation Marker with Tumor Immune Contexture Analysis

Almost 25% of lung cancers (LCs) occur in never-smokers. LC inflammatory profile, based on plasma C-reactive protein levels (CRP), predicts mortality, independently by smoking-status. We hypothesized that: CRP could be associated with tumor immune contexture (TIC) in never-smokers and both these two...

Descripción completa

Detalles Bibliográficos
Autores principales:	Milione, Massimo, Boeri, Mattia, Cantarutti, Anna, Centonze, Giovanni, Busico, Adele, Suatoni, Paola, Garzone, Giovanna, Cattaneo, Laura, Tamborini, Elena, Perrone, Federica, Mangogna, Alessandro, Corrao, Giovanni, Pruneri, Giancarlo, Sozzi, Gabriella, Anichini, Andrea, Pastorino, Ugo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408913/ https://www.ncbi.nlm.nih.gov/pubmed/32646072 http://dx.doi.org/10.3390/cancers12071828

Ejemplares similares

Beyond Traditional Morphological Characterization of Lung Neuroendocrine Neoplasms: In Silico Study of Next-Generation Sequencing Mutations Analysis across the Four World Health Organization Defined Groups
por: Centonze, Giovanni, et al.
Publicado: (2020)

Inflammatory status and lung function predict mortality in lung cancer screening participants
por: Pastorino, Ugo, et al.
Publicado: (2018)

Age-Related Alterations in Immune Contexture Are Associated with Aggressiveness in Rhabdomyosarcoma
por: Gasparini, Patrizia, et al.
Publicado: (2019)

Timeline of SARS-CoV-2 Spread in Italy: Results from an Independent Serological Retesting
por: Montomoli, Emanuele, et al.
Publicado: (2021)

COVID-19 Pandemic: Huge Stress Test for Health System Could Be a Great Opportunity to Update the Workflow in a Modern Surgical Pathology
por: Belfiore, Antonino, et al.
Publicado: (2021)

Assessment of Circulating microRNAs in Plasma of Lung Cancer Patients
por: Fortunato, Orazio, et al.
Publicado: (2014)

Gastroblastoma in Adulthood—A Rarity among Rare Cancers—A Case Report and Review of the Literature
por: Centonze, Giovanni, et al.
Publicado: (2019)

Myeloid and T-Cell Microenvironment Immune Features Identify Two Prognostic Sub-Groups in High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms
por: Centonze, Giovanni, et al.
Publicado: (2021)

Prolonged lung cancer screening reduced 10-year mortality in the MILD trial: new confirmation of lung cancer screening efficacy
por: Pastorino, U, et al.
Publicado: (2019)

Prolonged lung cancer screening reduced 10-year mortality in the MILD trial: new confirmation of lung cancer screening efficacy
por: Pastorino, U, et al.
Publicado: (2019)

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier (MSC) for Lung Cancer Screening
por: Mensah, Mavis, et al.
Publicado: (2017)

Microenvironment and tumor inflammatory features improve prognostic prediction in gastro‐entero‐pancreatic neuroendocrine neoplasms
por: Milione, Massimo, et al.
Publicado: (2019)

Cotargeting of miR‐126‐3p and miR‐221‐3p inhibits PIK3R2 and PTEN, reducing lung cancer growth and metastasis by blocking AKT and CXCR4 signalling
por: Di Paolo, Daniela, et al.
Publicado: (2021)

Development of a Molecular Blood-Based Immune Signature Classifier as Biomarker for Risks Assessment in Lung Cancer Screening
por: Fortunato, Orazio, et al.
Publicado: (2022)

Evaluation of Simplified Diet Scores Related to C-Reactive Protein in Heavy Smokers Undergoing Lung Cancer Screening
por: Sabia, Federica, et al.
Publicado: (2022)

Circulating extracellular vesicles from individuals at high-risk of lung cancer induce pro-tumorigenic conversion of stromal cells through transfer of miR-126 and miR-320
por: Pontis, Francesca, et al.
Publicado: (2021)

Circulating microRNA signature as liquid-biopsy to monitor lung cancer in low-dose computed tomography screening
por: Sestini, Stefano, et al.
Publicado: (2015)

Correction: Circulating microRNA signature as liquid-biopsy to monitor lung cancer in low-dose computed tomography screening
por: Sestini, Stefano, et al.
Publicado: (2019)

Mutational Profile from Targeted NGS Predicts Survival in LDCT Screening-Detected Lung Cancers
por: Verri, Carla, et al.
Publicado: (2017)

Pulmonary adenocarcinoma with mucin production modulates phenotype according to common genetic traits: a reappraisal of mucinous adenocarcinoma and colloid adenocarcinoma
por: Sonzogni, Angelica, et al.
Publicado: (2017)

Novel method to detect microRNAs using chip-based QuantStudio 3D digital PCR
por: Conte, Davide, et al.
Publicado: (2015)

Prognostic impact of ATM mutations in patients with metastatic colorectal cancer
por: Randon, Giovanni, et al.
Publicado: (2019)

C-reactive protein level predicts mortality in COPD: a systematic review and meta-analysis
por: Leuzzi, Giovanni, et al.
Publicado: (2017)

Lung carcinoid tumours: histology and Ki‐67, the eternal rivalry
por: Centonze, Giovanni, et al.
Publicado: (2022)

The Tumor Immune Contexture of Prostate Cancer
por: Vitkin, Natasha, et al.
Publicado: (2019)

Unexpected detection of SARS-CoV-2 antibodies in the prepandemic period in Italy
por: Apolone, Giovanni, et al.
Publicado: (2020)

Genetic differences between smokers and never-smokers with lung cancer
por: Kuśnierczyk, Piotr
Publicado: (2023)

Addiction to the nicotine gum in never smokers
por: Etter, Jean-François
Publicado: (2007)

mir-660-p53-mir-486 Network: A New Key Regulatory Pathway in Lung Tumorigenesis
por: Borzi, Cristina, et al.
Publicado: (2017)

MicroRNA Profile of Lung Tumor Tissues Is Associated with a High Risk Plasma miRNA Signature
por: Fortunato, Orazio, et al.
Publicado: (2016)

Never-smoker African–American women suffer more from COPD compared with never-smoker Caucasian women
por: Sumon, Mahbubur, et al.
Publicado: (2020)

Repeatability of dental shade by digital spectrophotometry in current, former, and never smokers
por: Conte, Gianluca, et al.
Publicado: (2022)

Toll-like receptor 3 as a new marker to detect high risk early stage Non-Small-Cell Lung Cancer patients
por: Bianchi, Francesca, et al.
Publicado: (2019)

Circulating mir‐320a promotes immunosuppressive macrophages M2 phenotype associated with lung cancer risk
por: Fortunato, Orazio, et al.
Publicado: (2019)

MiR-486-5p Targets CD133+ Lung Cancer Stem Cells through the p85/AKT Pathway
por: Moro, Massimo, et al.
Publicado: (2022)

AGER expression and alternative splicing in bronchial biopsies of smokers and never smokers
por: Faiz, Alen, et al.
Publicado: (2019)

Descriptive characteristics of hospitalized adult smokers and never-smokers with COVID-19
por: Kalan, Mohammad Ebrahimi, et al.
Publicado: (2020)

Are Complication Rates of Breast Reduction Similar in Former Smokers and Never Smokers?
por: Cruz, Norma
Publicado: (2021)

Distinct immune microenvironment of lung adenocarcinoma in never-smokers from smokers
por: Luo, Wenxin, et al.
Publicado: (2023)

Prevalence of BRCA homopolymeric indels in an ION Torrent-based tumour-to-germline testing workflow in high-grade ovarian carcinoma
por: Azzollini, Jacopo, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0pr520742cqf5obnhgr4vi1f4q